Home
News
Screeners
Insights
Roopa Industries
51.
00
+4.55
(+9.80%)
Market Cap
₹40.08 Cr
PE Ratio
290.31
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+9.80%
1M
+6.27%
6M
+14.61%
1Y
-5.92%
5Y
+240.00%
View Company Insights
Latest news about Roopa Industries
Roopa Industries Q1 Results: Net profit turns positive to ₹32.84 lakh
6 days ago
Roopa Industries Limited returned to profitability in Q1FY26 with a net profit of ₹32.84 lakh, recovering from a ₹143.33 lakh loss in the prior quarter. Revenue grew 10.2% sequentially to ₹3,334.76 lakh but trailed year-ago levels. EPS improved to ₹0.43.
Roopa Industries Q1 Results: Share transfer window opens
Aug 11, 2026
Roopa Industries reports net loss in Q4 FY26
Jun 02, 2026
Roopa Industries board to meet on May 30 for Q4FY26 results
May 20, 2026
Roopa Industries Submits SEBI Compliance Certificate for Q4 FY26 Dematerialization
Apr 09, 2026
More news about Roopa Industries
17
Feb 26
Roopa Industries Reports Q3FY26 Results with Revenue Growth Despite Fire Incident
Roopa Industries Limited delivered mixed Q3FY26 performance with revenue growth of 9.1% to ₹3,354.28 lacs and net profit rising marginally to ₹76.88 lacs. However, a fire accident at the Patancheru plant resulted in losses of ₹409.15 lacs, impacting overall operations.
10
Jan 26
Roopa Industries Limited Declares Record Date Under Regulation 42
Roopa Industries Limited has declared a record date under SEBI Regulation 42 and announced a special window for re-lodgement of physical share transfer requests running from July 7, 2025 to January 6, 2026. The company encourages shareholders to update KYC details and convert physical shares to dematerialized form.
Roopa Industries
51.
00
+
4.
55
(+
9.
80
%)
1 Year Returns:
-5.92%
Industry Peers
Sun Pharmaceutical
1,910.00
(+
0.
40
%)
Divis Laboratories
8,496.00
(-
1.
17
%)
Torrent Pharmaceuticals
4,886.50
(-
0.
20
%)
Cipla
1,437.90
(+
0.
40
%)
Zydus Life Science
1,103.80
(-
1.
45
%)
Lupin
2,188.00
(-
0.
63
%)
Dr Reddys Laboratories
1,190.00
(+
1.
30
%)
Mankind Pharma
2,374.50
(-
0.
40
%)
Laurus Labs
1,801.00
(-
0.
06
%)
Aurobindo Pharma
1,608.00
(-
0.
82
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar